Novelix Pharma.

{
  "main_header": {
    "sid": 200695,
    "name": "Novelix Pharma.",
    "stock_name": "Novelix Pharma.",
    "full_name": "Novelix Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/novelix-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "54.36",
    "chg": 1.69,
    "chgp": "3.21%",
    "dir": 1,
    "prev_price": "52.67",
    "mcapval": "133.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 536565,
    "symbol": "",
    "ind_name": "Retailing",
    "ind_code": 4,
    "sector_id": 72,
    "indexname": "India SENSEX",
    "isin": "INE314I01036",
    "curr_date": "Jun 03, 03:30 PM",
    "curr_time": "00:21 AM",
    "last_traded_at": "Jun 03, 03:30 PM IST",
    "bse_nse_vol": "3.78 k",
    "exc_status": "Active",
    "traded_date": "Jun 03, 2026",
    "traded_date_str": "2026 06 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/novelix-pharma-200695-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Novelix Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4029035",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovelixPharmace_valuationdot_4029035.png",
        "date": "2026-06-02 08:00:38",
        "description": "Novelix Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, reflecting a more attractive price point for investors. This change comes amid a mixed performance backdrop and evolving market dynamics within the retailing sector."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-4026280",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovelixPharmace_mojoScore_4026280.png",
        "date": "2026-06-01 10:10:04",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 01 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "When is the next results date for Novelix Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-novelix-pharmaceuticals-ltd-4015367",
        "imagepath": "",
        "date": "2026-05-26 23:21:42",
        "description": "The next results date for Novelix Pharmaceuticals Ltd is scheduled for 29 May 2026...."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4002904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NovelixPharmace_mojoScore_4002904.png",
        "date": "2026-05-21 10:10:05",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-3984138",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NovelixPharmace_mojoScore_3984138.png",
        "date": "2026-05-10 10:10:02",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-3968213",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NovelixPharmace_mojoScore_3968213.png",
        "date": "2026-04-29 10:10:03",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-3952127",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NovelixPharmace_mojoScore_3952127.png",
        "date": "2026-04-18 10:10:03",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-3935332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NovelixPharmace_mojoScore_3935332.png",
        "date": "2026-04-07 10:10:02",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-3917977",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NovelixPharmace_mojoScore_3917977.png",
        "date": "2026-03-26 10:10:02",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of its performance and outlook."
      }
    ],
    "total": 122,
    "sid": "200695",
    "stock_news_url": "https://www.marketsmojo.com/news/novelix-pharmaceuticals-200695"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "02-Jun-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Srindhi Fine Chemicals LLP",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015",
      "datetime": "02-Jun-2026",
      "details": "Submission of Intimation of Allotment of equity shares to promoters and promoter group.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "01-Jun-2026",
      "details": "Trading window closure intimation.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(04 Jun 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has declared <strong>3%</strong> dividend, ex-date: 16 Aug 12",
          "dt": "2012-08-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has announced <strong>10:1</strong> stock split, ex-date: 04 Oct 10",
          "dt": "2010-10-04",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Novelix Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness

2026-06-02 08:00:38

Novelix Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, reflecting a more attractive price point for investors. This change comes amid a mixed performance backdrop and evolving market dynamics within the retailing sector.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold by MarketsMOJO

2026-06-01 10:10:04

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 01 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

When is the next results date for Novelix Pharmaceuticals Ltd?

2026-05-26 23:21:42

The next results date for Novelix Pharmaceuticals Ltd is scheduled for 29 May 2026....

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-05-21 10:10:05

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-05-10 10:10:02

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-04-29 10:10:03

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-04-18 10:10:03

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-04-07 10:10:02

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-03-26 10:10:02

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of its performance and outlook.

Read full news article

View All News